News

Press Releases
Tolera Therapeutics granted Orphan Drug Designation for treatment of Type 1 diabetes mellitus	June 22, 2010
Tolera Therapeutics Honored as One of the 2010 “Michigan 50 Companies to Watch”	April 6, 2010
Tolera files IND application for TOL101, O'Toole to lead clinical operations	November 3, 2009
Tolera granted Orphan Drug Designation for organ transplant rejection drug	April 7, 2009
TOL101 enters study in DOD's AFIRM research initiative	April 1, 2009
Tolera Raises $8 Million	June 16, 2008
Tolera adds new Board Members	June 16, 2008
Parfet named to Tolera Board	May 1, 2007

Tolera Articles
Tolera Therapeutics gets $4M for organ transplant rejection drug	MedCity News, June 7, 2010
Breaking New Ground: Surgeon Maria Siemionow sees...	Continental Magazine, June 2010
Tolera: Delta force improves tolerance	BioCentury, Jan. 11, 2010
First Face Transplant Performed in the U.S.	New York Times, Dec. 17,2008
Tolera Wins $2 Million in 21st Century Jobs Business Plan Competition	Ann Arbor Business Review, 2008
About Face: The Surgeon Behind the Mask	Cleveland Clinic Magazine, Spring 2006
The next step in face transplants being planned	CNN, 12/26/2006
Preparing for the world's first face transplants	MSNBC, 11/21/2005
Plans advancing for world's first face transplant	USA Today, 9/18/2005
A New Face: A Bold Surgeon, an Untried Surgery	The New York Times, 7/26/2005
Surgery's next step: face transplants	Chicago Tribune, 6/12/2005
Years of minute research leading surgeon toward first facial transplant	The Plain Dealer, 10/31/04